FAQ: American Heart Association Acquisition of Cardiometabolic Center Alliance

What is the main purpose of this collaboration between the American Heart Association and CMCA?

The collaboration aims to establish integrated care that holistically manages cardiovascular, kidney, and metabolic health by combining resources and expertise from both organizations to provide comprehensive, patient-centered care.

Why is this partnership significant for patient care?

This partnership is significant because it enables the expansion and scaling of proven team-based care models that have shown statistically significant improvements in quality of care and clinical outcomes for patients with cardiometabolic disease.

How does the CMCA’s care model differ from traditional approaches?

The CMCA’s model treats Type 2 diabetes, pre-diabetes, and related cardiovascular conditions together using a team-based approach tailored to each patient, rather than addressing conditions or risk factors separately.

Who founded the Cardiometabolic Center Alliance and where did it originate?

The CMCA was founded by Saint Luke’s Mid America Heart Institute in Kansas City, Missouri, under the medical direction of Mikhail Kosiborod, M.D., through the Saint Luke’s Michael and Marlys Haverty Cardiometabolic Center of Excellence.

When was the Cardiometabolic Center Alliance launched and when was this acquisition announced?

The CMCA was launched in 2020, and this acquisition was announced for release on October 1, 2025.

What specific resources and expertise does CMCA bring to this partnership?

CMCA brings clinical protocols, clinical materials, program support for 22 cardiometabolic centers, and a five-year longitudinal dataset of patient-level cardiometabolic data.

What will happen to CMCA leadership as part of this transition?

CMCA leadership will transition to committee and staff roles at the American Heart Association, ensuring continuity of expertise and program knowledge.

How will this collaboration impact the development of certification programs?

The strengths and expertise of CMCA will enhance the American Heart Association’s development of a Cardiovascular-Kidney-Metabolic Center of Excellence certification program.

What evidence supports the effectiveness of the CMCA care model?

The care model has been recognized in top medical journals, and CMCA members have observed statistically significant improvements in quality of care and clinical outcomes.

Where can people find more information about this collaboration?

People can follow AHA/ASA news on X @HeartNews for additional information and updates about this collaboration.